2018年5月
Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
Journal of gastroenterology
- 巻
- 53
- 号
- 5
- 開始ページ
- 689
- 終了ページ
- 689
- 記述言語
- 英語
- 掲載種別
- 研究論文（学術雑誌）
- DOI
- 10.1007/s00535-017-1409-z
Unfortunately, in the original publication of this article, the copyright line was incorrectly published in PDF as "© The Author(s) 2017" instead of "©The Author(s) 2017 This article is an open access publication" and also the CC-BY description was not included. The description should be as follows.
- リンク情報
- ID情報
-
- DOI : 10.1007/s00535-017-1409-z
- PubMed ID : 29134328
- PubMed Central 記事ID : PMC5910493